Genentech Recalls Nutropin AQ NuSpin 20 Due to Defective Delivery System
Genentech is recalling 10,306 syringes of Nutropin AQ NuSpin 20 because the dose knob may spin slowly, causing delayed injection delivery.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the issue involves a mechanical defect in the delivery system that affects the speed of injection rather than the safety or purity of the drug itself, fitting the criteria for a moderate risk.
Plain-English summary
Genentech Inc is recalling 10,306 syringes of Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection) 20 mg/2mL. The affected product is identified by Lot #936674 with an expiration date of 09/30/13. The recall is being conducted nationwide.
The recall was initiated after Genentech received complaints regarding the Nutropin AQ NuSpin 10 and 20 delivery systems. Users reported that the dose knob spun slowly and that the injection process took longer than usual, indicating slow dose delivery.
Consumers who have this specific lot of Nutropin AQ NuSpin 20 should stop using the product and contact Genentech or their healthcare provider for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0076-01
- Manufacturer
- Genentech Inc
- Category
- Drug — Biologic / Injection
- Affected units
- 10,306
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot# 936674 Exp. 09/30/13
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Genentech Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Genentech Inc
See all →- HighCathflo Activase Injection Vials Recalled Due to Deformed Stoppers
FDA (Drugs) · 2024-06-05
- ModerateRanibizumab eye implant recalled for non-functioning delivery system
FDA (Drugs) · 2022-11-09
- ModerateGenentech Xolair Injection Recalled for Failed Stability Specifications
FDA (Drugs) · 2021-07-14
- LowGenentech Recalls Evrysdi Oral Solution Due to Defective Bottle Adapters
FDA (Drugs) · 2021-05-05
- LowGenentech Recalls Klonopin Tablets Due to Missing Schedule IV Labeling
FDA (Drugs) · 2018-02-21
Same hazard · defective delivery system
See all →- HighAmneal Recalls Exenatide Injection Pens Due to Potential Empty Delivery System
FDA (Drugs) · 2026-09-30
- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- HighAIRSUPRA Albuterol and Budesonide Inhalation Aerosol Recalled for Defective Delivery System
FDA (Drugs) · 2025-05-28
- HighLorazepam Oral Syringes Recalled Due to Defective Delivery System Causing Leakage
FDA (Drugs) · 2025-03-12
- ModerateVarithena Administration Pack Recalled Due to Incorrect Syringe Connector Type
FDA (Drugs) · 2024-12-18
Similar recalls
- HighNovo Nordisk Recalls Norditropin Pens Due to Delivery System Defect
FDA (Drugs) · 2016-06-15
- SevereSanofi Recalls Auvi-Q Epinephrine Auto-Injectors Due to Defective Delivery System
FDA (Drugs) · 2016-06-01
- ModerateGenentech Xolair Injection Recalled for Failed Stability Specifications
FDA (Drugs) · 2021-07-14
- ModerateFresenius Kabi Recalls Gentamicin Vials Due to Missing Stoppers
FDA (Drugs) · 2014-12-17
- HighEpinephrine Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-27
- ModerateAdvanced Pharma Recalls NitroGlycerin Syringes Due to Stability Data Issues
FDA (Drugs) · 2017-12-27